Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Deutsche Bank upgrades Barclays but Citi isn’t convinced

David Lock, Deutsche analyst, in a note, said the bank sent a strong statement of confidence with its dividend and promises of buy-backs
Barclays office
Deutsche's target is 250p but Citi's is pitched at 150p.

A pair of blue-chip analysts today had contrasting views on Barclays PLC (LON:BARC), with Deutsche Bank upgrading its target price, but, Citigroup repeated a sell recommendation.

Deutsche lifted the target price to 250p, from 234p, and repeated a ‘buy’ rating.

READ: Barclays swings to 2017 loss but shares gain on plans to restore dividend

David Lock, Deutsche analyst, in a note, said the bank sent a strong statement of confidence with its dividend and promises of buy-backs.

“Now the bank’s capital position is removed as the main market concern, the focus turns to revenues: after stabilizing in 2017, Barclays needs to deliver c.£2.5bn revenue growth over 2018-19 in order to reach its RoTE target of >9%,” Lock said.

He added that forex headwinds are a near term issue, but, there’s “cause for some optimism” including expected growth for UK and US retail banking as well as strong potential for improvement in corporate revenues.

Pouring cold water, meanwhile, Citi analyst Andrew Coombs repeated a ‘sell’ and a 150p target.

“The Barclays investment proposition depends on the credibility of the financial targets, which rely on the ability to grow revenues again (at a c4-5% CAGR), following five consecutive years of decline,” Coombes said in a note.

“We view this as challenging.”

Specifically, the analyst reckons Barclay’s investment banking business will be key and, seemingly, he doesn’t fancy Barclay’s chances.

“We believe it could take a pro-longed period of time to turn around the struggling investment bank, rather than the (quick) 2-3 year plan outlined by management,” Coombes added.

View full BARC profile View Profile

Barclays Timeline

Related Articles

April 24 2018
Redfund is positioning itself to become a top-tier cannabis incubator and accelerator

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use